Feb 20 2024
In December, 2022, President Biden signed the Medical Marijuana and Cannabidiol Research Expansion Act into law, making it the first standalone piece of marijuana legislation to ever be signed by a US president.
Since then, lawmakers have filed multiple marijuana-related bills seeking to bring further reforms to America’s marijuana laws.
Continue reading
Feb 20 2024
According to data released by the Arizona Department of Revenue, the state made $23,737,758 in taxes from legal marijuana sales in December. This brings the total for 2023 to $252,872,787.
The total amount of marijuana taxes made since the start of legal marijuana sales in 2021 now stands at $757,471,288.
Continue reading
Feb 20 2024
In an overwhelming 43 to 2 vote, the Maryland Senate voted today to pass Senate Bill 348, sending it to the House of Representatives. The measure was filed last month by Senator Mike McKay (R).
The legislation states that “a person may not be denied the right to purchase, own, possess, or carry a firearm solely on the basis that the person is authorized to use medical cannabis”.
Continue reading
Feb 20 2024
Dried psilocybin mushrooms.
Senate Bill 1570 has been given approval by the Senate Rules Committee in a 5 to 2 vote. Passage through the committee comes six days after it was passed unanimously by the Senate Health and Human Services Committee.
The proposed law would legalize psilocybin therapy centers where individuals can come and legally consume psilocybin in a medical, supervised setting, with trained staff constantly available. Licensing for these centers would be handled by the Department of Human Services (DHS).
Continue reading
Feb 19 2024
Nebraska is one of just a dozen states that have not legalized medical marijuana. New polling commissioned by the Neilan Strategy Group, and conducted by Data Targeting Inc., shows that 70% of voters in the state want that to change.
“Nebraskans are clearly ready to legalize medical marijuana,” said Perre Neilan of Neilan Strategy Group.
Continue reading
Feb 19 2024
The Senate Committee on Commerce and Labor voted 14 to 0 today to pass House Bill 149, which was passed by the full House of Delegates on January 29, with the vote being 78 to 20. If the measure is passed by the full Senate, it will be sent to Governor Glenn Youngkin.
Under current law “No employer shall discharge, discipline, or discriminate against an employee for such employee’s lawful use of cannabis oil pursuant to a valid written certification issued by a practitioner for the treatment or to eliminate the symptoms of the employee’s diagnosed condition or disease”.
Continue reading
Feb 19 2024
The committee voted today to pass Second Substitute House Bill 2320, sending it to the Ways and Means Committee. The measure was passed by the full House of Representatives earlier this month 92 to 5.
According to its official legislative summary, the measure “Requires the Department of Health to develop optional training for retail cannabis staff as well as a notice that cannabis retailers must conspicuously post at the point of sale for consumers, related to possible health risks and impacts of high-tetrahydrocannabinol (THC) cannabis and available resources.”
Continue reading
Feb 19 2024
The Senate Labor and Commerce Committee voted unanimously today to pass House Bill 1453, sending it to the Ways and Means Committee. The measure was approved through the full House of Representatives 85 to 12 last week
The proposed law “Provides a permanent tax exemption from the 37 percent cannabis excise tax for qualifying patients and designated providers with a recognition card on purchases of cannabis products that are labeled as Department of Health (DOH)-compliant product and tested in accordance with the DOH’s rules.”
Continue reading
Feb 19 2024
In August, in a letter addressed to DEA Administrator Anne Milgram, the Department of Health and Human Services (HHS) asked for marijuana to be reclassified as a Schedule III drug under the Federal Controlled Substances Act following a nearly year-long review at the FDA.
Now, the FDA says that when conducting its review, the agency not only examined a plethora of scientific research, they had a team of researchers who spent months analyzing thousands of posts on various social media platforms, many of which were marijuana consumers putting forth anecdotal evidence of its therapeutic and medical benefits.
Continue reading
Feb 19 2024
Dried psilocybin mushrooms.
The House Consumer Protection and Commerce Committee has voted 7 to 0 to pass House Bill 2630, filed last month by State Representative Della au Belatti along with 13 cosponsors. The measure has already been approved by the Judiciary & Hawaiian Affairs Committee (10 to 0) the Health & Homelessness Committee (7 to 1).
The measure must now be passed by the House Finance Committee before it can be considered by the full House.
Continue reading
